Showing results (931-940 of 2,010) with videos related to
Sort By:
Pageof 201
Vaccine|February 1, 1997
A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeuticsC A Hanlon, M Niezgoda, V Shankar, et al.Coronary Artery Disease|December 1, 1996
Evaluation of post-myocardial infarction regional and global left ventricular function by monoplane ventriculography: superiority of right versus left anterior oblique projection at any infarct locationU Nixdorff, S Kissler, R Erbel, et al.Journal of Wildlife Diseases|May 13, 1998
First North American field release of a vaccinia-rabies glycoprotein recombinant virusC A Hanlon, M Niezgoda, A N Hamir, et al.Proteomics|April 11, 2025
Association of Urinary Collagen Type III Degradation Product With Kidney Function and Fibrosis in Chronic Kidney Disease PatientsEmily M Martin, Federica Genovese, Harald Mischak, et al.Journal of Wildlife Diseases|August 13, 2003
Rabies among infrequently reported mammalian carnivores in the United States, 1960-2000John W Krebs, Sarah M Williams, Jean S Smith, et al.The Biochemical Journal|May 23, 1998
Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteinsC O Reiser, T Lanz, F Hofmann, et al.Journal of Theoretical Biology|December 23, 2006
Integrative models of bat rabies immunology, epizootiology and disease demographyDobromir T Dimitrov, Thomas G Hallam, Charles E Rupprecht, et al.Revue Scientifique Et Technique (International Office of Epizootics)|July 18, 2007
Vaccination in conservation medicineG Plumb, L Babiuk, J Mazet, et al.International Journal of Molecular Sciences|August 7, 2021
Mechanisms Governing Anaphylaxis: Inflammatory Cells, Mediators, Endothelial Gap Junctions and BeyondSamantha Minh Thy Nguyen, Chase Preston Rupprecht, Aaisha Haque, et al.Journal of Neuroendocrinology|May 26, 2011
Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profileC Nothdurfter, G Rammes, T C Baghai, et al.Pageof 201